Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001829126-25-007608
Filing Date
2025-09-23
Accepted
2025-09-23 16:30:57
Documents
22
Period of Report
2025-10-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A novabay_def14a.htm   iXBRL DEF 14A 1228759
2 GRAPHIC img_001.jpg GRAPHIC 13206
3 GRAPHIC img_002.jpg GRAPHIC 20386
4 GRAPHIC img_003.jpg GRAPHIC 60271
5 GRAPHIC img_004.jpg GRAPHIC 62861
6 GRAPHIC proxy_001.jpg GRAPHIC 224691
7 GRAPHIC proxy_002.jpg GRAPHIC 157873
  Complete submission text file 0001829126-25-007608.txt   3238360

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cik0001389545-20241231.xsd EX-101.SCH 5705
9 XBRL DEFINITION FILE cik0001389545-20241231_def.xml EX-101.DEF 9525
10 XBRL LABEL FILE cik0001389545-20241231_lab.xml EX-101.LAB 58737
11 XBRL PRESENTATION FILE cik0001389545-20241231_pre.xml EX-101.PRE 41926
24 EXTRACTED XBRL INSTANCE DOCUMENT novabay_def14a_htm.xml XML 107976
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 251334000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)